Related Experiment Video
Updated: Sep 15, 2025

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
A Novel Polymorphic Form of Sodium Benzoate (Ω-NaBen): Improved Solubility, Stability, Central Nervous System
Wei-Hua Chang1, Yi-An Lai1, Hsing-Chun Tsai1
1Department of Research and Development, SyneuRx International Corp, New Taipei City, Taiwan.
Introduction:
Sodium benzoate (NaBen), a D-amino acid oxidase inhibitor, has been demonstrated to possess antipsychotic and cognition-enhancing effects in animal models. However, the clinical findings in patients with schizophrenia and dementia are mixed and inconclusive. To further improve its therapeutic potential, a novel crystalline polymorph of NaBen (Ω-NaBen) was developed. This study evaluated the physicochemical properties and central nervous system (CNS) effects of Ω-NaBen.
Methods:
The novel crystalline structure of Ω-NaBen was confirmed by thermogravimetric analysis, differential scanning calorimetry, and X-ray powder diffractometry. Water solubility test and stability test were performed to compare its physicochemical properties. The CNS exposure and D-amino acids levels in brain subregions of Ω-NaBen- and non-Ω-NaBen-treated male mice were determined with LC-MS/MS. Therapeutic effects of Ω-NaBen in the MK-801-induced mouse model were assessed by the open field test, novel object recognition test, and three-chamber social test.
Results:
Our findings indicated that Ω-NaBen had a unique crystalline structure and showed better aqueous solubility and crystal stability, either with or without clozapine, compared with amorphous NaBen. Ω-NaBen also showed improved CNS exposure and induced higher levels of D-serine or/and D-alanine in the brain. In MK-801-treated mice, Ω-NaBen displayed enhanced effects in alleviating hyperactivity and stronger potency in relieving cognitive impairment. It also improved efficacy in relieving social deficit, a negative symptom model of schizophrenia.
Discussion:
This study indicates that the crystalline structure critically influences the potency of bioactive compounds and may represent a rational strategy for optimizing pharmaceutical development.
Conclusion:
Our study demonstrated Ω-NaBen's promising potential as a novel CNS therapeutic due to its favorable physicochemical properties, CNS exposure, and neurochemical and behavioral effects.
More Related Videos
Related Concept Videos
Diazonium Group Substitution: –OH and –H
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Nucleophilic Aromatic Substitution of Aryldiazonium Salts: Aromatic SN1
In the Sandmeyer reaction, for example, the diazonio group is replaced by a chloro, bromo,...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Anxiolytic Drugs: Benzodiazepines and Buspirone
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...

